Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nabilone for Agitation Blinded Intervention Trial

NCT04516057 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT04516057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04516057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nabilone for Agitation Blinded Intervention Trial
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Phase 3
Overall status
Recruiting
Start date
February 1, 2021
Completion date
April 30, 2027
Enrollment
112 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

agitation, alzheimer disease